Page breadcrumb nav

VAERS Report 2157102

Case Report Section

Détails du rapport Vaer

Âge: N/A

Genre: Female

Région : Outside US

Patient décédé?
Non
Renseignements sur les vaccins

Nom: COVID19 (COVID19 (PFIZER-BIONTECH))

Type : Coronavirus 2019 vaccine

Fabricant: PFIZER

Lot: unknown


Date de réception du rapport
2022-03-04
Date à laquelle le formulaire est complèté
Date de vaccination
2021-12-01
Date d’apparition
31
Nombre de jours (date d’apparition – date de vaccination)
31
Description de l’événement indésirable

breast carcinoma; this is a spontaneous report received from contactable healthcare professional (hcp). a 45 year-old female patient (not pregnant) received bnt162b2 (comirnaty), intramuscular, administration date dec2021 (lot number: unknown) as dose 3 (booster), single for covid-19 immunisation. there was no relevant medical history. concomitant medications were not reported. vaccination history included: comirnaty (dose number: 2, batch/lot no: unknown. not available/provided to reporter at the time of report completion), administration date: jun2021, for covid-19 immunisation; comirnaty (dose number: 1, batch/lot no: unknown. not available/provided to reporter at the time of report completion), administration date: may2021, for covid-19 immunisation. the patient did not receive any other vaccines within 4 weeks prior to the covid vaccine. prior to vaccination, the patient was not diagnosed with covid-19. the following information was reported: breast carcinoma (hospitalization in jan2022, life threatening) with onset jan2022. the patient underwent regular gynecological testing a month after the third dose of the comirnaty vaccine in jan2022. digital mammography, ultrasound and palpation showed an oversized tumor in the right breast and an urgent biopsy was decided which confirmed malignancy in jan2022. the event breast carcinoma was evaluated at the physician office visit. a mastectomy was performed, the other imaging and hematological examinations showed no signs of other malignancy or metastasis in jan2022. after the surgical recovery, the patient has already started chemotherapy. the outcome of the event breast carcinoma was recovering. since the vaccination, it was unknown if the patient been tested for covid-19. no follow-up attempts are possible; information about lot/batch number cannot be obtained. no further information is expected.; sender's comments: the event breast carcinoma is considered as intercurrent condition and unrelated to product bnt162b2 (comirnaty)

Données de laboratoire
test date: 202201; test name: biopsy; result unstructured data: test result:confirmed malignancy; test date: 202201; test name: hematological examinations; result unstructured data: test result:showed no signs of other malignancy or metastasis; test date: 202201; test name: other imaging; result unstructured data: test result:showed no signs of other malignancy or metastasis; test date: 202201; test name: digital mammography; result unstructured data: test result:oversized tumor in the right breast; test date: 202201; test name: ultrasound; result unstructured data: test result:oversized tumor in the right breast
Liste des symptômes
biopsy breast cancer ultrasound scan haematology test normal mammogram imaging procedure
Patient décédé?
Non
Date de décès
N/A
Anomalie congénitale
false
Vaccin administré par :
Other
Vaccin acheté par :
Inconnu
Visite d’un patient à l’urgence?
Non
Patient hospitalisé?
Oui
Séjour à l’hôpital
Non
Nombre de jours à l’hôpital
Non spécifié
Invalidité permanente?
Non
Allergies:
na
Maladie actuelle
na